In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL

Affiliations

• ¹ Tampere Center for Child Health Research, University of Tampere, and Tampere University Hospital, Tampere, Finland.
• ² Institute of Biomedicine, School of Medicine, University of Eastern Finland, Kuopio, Finland.
• ³ Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland.
• ⁴ Department of Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, The Netherlands.
• ⁵ Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.
• ⁶ Department of Clinical Science, Hematology Section, University of Bergen, Bergen, Norway.
• ⁷ Department of Internal Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway.
• ⁸ Department of Hematology, Hematology Research Unit Helsinki, University of Helsinki, and Helsinki University Central Hospital Cancer Center, Helsinki, Finland.